Global Narcolepsy Therapeutics Market Professional Survey Report 2017

November 2017 | 103 pages | ID: GC581E576D5EN
QYResearch

Abstracts

This report studies Narcolepsy Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Addrenex Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd.
• Jazz Pharmaceuticals PLC
• Graymark Healthcare, Inc.
• Arena Pharmaceuticals, Inc.
• BIOPROJET
• Shire
• Ligand Pharmaceuticals, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Central nervous system stimulants
• Sodium Oxybate
• Selective Serotonin Reuptake Inhibitor (SSRI)
• Tricyclic Antidepressants
• Others

By Application, the market can be split into

• Narcolepsy With Cataplexy
• Narcolepsy Without Cataplexy
• Secondary Narcolepsy

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Narcolepsy Therapeutics Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF NARCOLEPSY THERAPEUTICS

1.1 Definition and Specifications of Narcolepsy Therapeutics
  1.1.1 Definition of Narcolepsy Therapeutics
  1.1.2 Specifications of Narcolepsy Therapeutics
1.2 Classification of Narcolepsy Therapeutics
  1.2.1 Central nervous system stimulants
  1.2.2 Sodium Oxybate
  1.2.3 Selective Serotonin Reuptake Inhibitor (SSRI)
  1.2.4 Tricyclic Antidepressants
  1.2.5 Others
1.3 Applications of Narcolepsy Therapeutics
  1.3.1 Narcolepsy With Cataplexy
  1.3.2 Narcolepsy Without Cataplexy
  1.3.3 Secondary Narcolepsy
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF NARCOLEPSY THERAPEUTICS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Narcolepsy Therapeutics
2.3 Manufacturing Process Analysis of Narcolepsy Therapeutics
2.4 Industry Chain Structure of Narcolepsy Therapeutics

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF NARCOLEPSY THERAPEUTICS

3.1 Capacity and Commercial Production Date of Global Narcolepsy Therapeutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Narcolepsy Therapeutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Narcolepsy Therapeutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Narcolepsy Therapeutics Major Manufacturers in 2016

4 GLOBAL NARCOLEPSY THERAPEUTICS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Narcolepsy Therapeutics Capacity and Growth Rate Analysis
  4.2.2 2016 Narcolepsy Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Narcolepsy Therapeutics Sales and Growth Rate Analysis
  4.3.2 2016 Narcolepsy Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Narcolepsy Therapeutics Sales Price
  4.4.2 2016 Narcolepsy Therapeutics Sales Price Analysis (Company Segment)

5 NARCOLEPSY THERAPEUTICS REGIONAL MARKET ANALYSIS

5.1 North America Narcolepsy Therapeutics Market Analysis
  5.1.1 North America Narcolepsy Therapeutics Market Overview
  5.1.2 North America 2012-2017E Narcolepsy Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Narcolepsy Therapeutics Sales Price Analysis
  5.1.4 North America 2016 Narcolepsy Therapeutics Market Share Analysis
5.2 China Narcolepsy Therapeutics Market Analysis
  5.2.1 China Narcolepsy Therapeutics Market Overview
  5.2.2 China 2012-2017E Narcolepsy Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Narcolepsy Therapeutics Sales Price Analysis
  5.2.4 China 2016 Narcolepsy Therapeutics Market Share Analysis
5.3 Europe Narcolepsy Therapeutics Market Analysis
  5.3.1 Europe Narcolepsy Therapeutics Market Overview
  5.3.2 Europe 2012-2017E Narcolepsy Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Narcolepsy Therapeutics Sales Price Analysis
  5.3.4 Europe 2016 Narcolepsy Therapeutics Market Share Analysis
5.4 Southeast Asia Narcolepsy Therapeutics Market Analysis
  5.4.1 Southeast Asia Narcolepsy Therapeutics Market Overview
  5.4.2 Southeast Asia 2012-2017E Narcolepsy Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Narcolepsy Therapeutics Sales Price Analysis
  5.4.4 Southeast Asia 2016 Narcolepsy Therapeutics Market Share Analysis
5.5 Japan Narcolepsy Therapeutics Market Analysis
  5.5.1 Japan Narcolepsy Therapeutics Market Overview
  5.5.2 Japan 2012-2017E Narcolepsy Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Narcolepsy Therapeutics Sales Price Analysis
  5.5.4 Japan 2016 Narcolepsy Therapeutics Market Share Analysis
5.6 India Narcolepsy Therapeutics Market Analysis
  5.6.1 India Narcolepsy Therapeutics Market Overview
  5.6.2 India 2012-2017E Narcolepsy Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Narcolepsy Therapeutics Sales Price Analysis
  5.6.4 India 2016 Narcolepsy Therapeutics Market Share Analysis

6 GLOBAL 2012-2017E NARCOLEPSY THERAPEUTICS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Narcolepsy Therapeutics Sales by Type
6.2 Different Types of Narcolepsy Therapeutics Product Interview Price Analysis
6.3 Different Types of Narcolepsy Therapeutics Product Driving Factors Analysis
  6.3.1 Central nervous system stimulants of Narcolepsy Therapeutics Growth Driving Factor Analysis
  6.3.2 Sodium Oxybate of Narcolepsy Therapeutics Growth Driving Factor Analysis
  6.3.3 Selective Serotonin Reuptake Inhibitor (SSRI) of Narcolepsy Therapeutics Growth Driving Factor Analysis
  6.3.4 Tricyclic Antidepressants of Narcolepsy Therapeutics Growth Driving Factor Analysis
  6.3.5 Others of Narcolepsy Therapeutics Growth Driving Factor Analysis

7 GLOBAL 2012-2017E NARCOLEPSY THERAPEUTICS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Narcolepsy Therapeutics Consumption by Application
7.2 Different Application of Narcolepsy Therapeutics Product Interview Price Analysis
7.3 Different Application of Narcolepsy Therapeutics Product Driving Factors Analysis
  7.3.1 Narcolepsy With Cataplexy of Narcolepsy Therapeutics Growth Driving Factor Analysis
  7.3.2 Narcolepsy Without Cataplexy of Narcolepsy Therapeutics Growth Driving Factor Analysis
  7.3.3 Secondary Narcolepsy of Narcolepsy Therapeutics Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF NARCOLEPSY THERAPEUTICS

8.1 Addrenex Pharmaceuticals, Inc.
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Addrenex Pharmaceuticals, Inc. 2016 Narcolepsy Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Addrenex Pharmaceuticals, Inc. 2016 Narcolepsy Therapeutics Business Region Distribution Analysis
8.2 Teva Pharmaceutical Industries Ltd.
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Teva Pharmaceutical Industries Ltd. 2016 Narcolepsy Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Teva Pharmaceutical Industries Ltd. 2016 Narcolepsy Therapeutics Business Region Distribution Analysis
8.3 Jazz Pharmaceuticals PLC
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Jazz Pharmaceuticals PLC 2016 Narcolepsy Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Jazz Pharmaceuticals PLC 2016 Narcolepsy Therapeutics Business Region Distribution Analysis
8.4 Graymark Healthcare, Inc.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Graymark Healthcare, Inc. 2016 Narcolepsy Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Graymark Healthcare, Inc. 2016 Narcolepsy Therapeutics Business Region Distribution Analysis
8.5 Arena Pharmaceuticals, Inc.
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Arena Pharmaceuticals, Inc. 2016 Narcolepsy Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Arena Pharmaceuticals, Inc. 2016 Narcolepsy Therapeutics Business Region Distribution Analysis
8.6 BIOPROJET
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 BIOPROJET 2016 Narcolepsy Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 BIOPROJET 2016 Narcolepsy Therapeutics Business Region Distribution Analysis
8.7 Shire
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Shire 2016 Narcolepsy Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Shire 2016 Narcolepsy Therapeutics Business Region Distribution Analysis
8.8 Ligand Pharmaceuticals, Inc.
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Ligand Pharmaceuticals, Inc. 2016 Narcolepsy Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Ligand Pharmaceuticals, Inc. 2016 Narcolepsy Therapeutics Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF NARCOLEPSY THERAPEUTICS MARKET

9.1 Global Narcolepsy Therapeutics Market Trend Analysis
  9.1.1 Global 2017-2022 Narcolepsy Therapeutics Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Narcolepsy Therapeutics Sales Price Forecast
9.2 Narcolepsy Therapeutics Regional Market Trend
  9.2.1 North America 2017-2022 Narcolepsy Therapeutics Consumption Forecast
  9.2.2 China 2017-2022 Narcolepsy Therapeutics Consumption Forecast
  9.2.3 Europe 2017-2022 Narcolepsy Therapeutics Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Narcolepsy Therapeutics Consumption Forecast
  9.2.5 Japan 2017-2022 Narcolepsy Therapeutics Consumption Forecast
  9.2.6 India 2017-2022 Narcolepsy Therapeutics Consumption Forecast
9.3 Narcolepsy Therapeutics Market Trend (Product Type)
9.4 Narcolepsy Therapeutics Market Trend (Application)

10 NARCOLEPSY THERAPEUTICS MARKETING TYPE ANALYSIS

10.1 Narcolepsy Therapeutics Regional Marketing Type Analysis
10.2 Narcolepsy Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Narcolepsy Therapeutics by Region
10.4 Narcolepsy Therapeutics Supply Chain Analysis

11 CONSUMERS ANALYSIS OF NARCOLEPSY THERAPEUTICS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL NARCOLEPSY THERAPEUTICS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Narcolepsy Therapeutics
Table Product Specifications of Narcolepsy Therapeutics
Table Classification of Narcolepsy Therapeutics
Figure Global Production Market Share of Narcolepsy Therapeutics by Type in 2016
Figure Central nervous system stimulants Picture
Table Major Manufacturers of Central nervous system stimulants
Figure Sodium Oxybate Picture
Table Major Manufacturers of Sodium Oxybate
Figure Selective Serotonin Reuptake Inhibitor (SSRI) Picture
Table Major Manufacturers of Selective Serotonin Reuptake Inhibitor (SSRI)
Figure Tricyclic Antidepressants Picture
Table Major Manufacturers of Tricyclic Antidepressants
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Narcolepsy Therapeutics
Figure Global Consumption Volume Market Share of Narcolepsy Therapeutics by Application in 2016
Figure Narcolepsy With Cataplexy Examples
Table Major Consumers in Narcolepsy With Cataplexy
Figure Narcolepsy Without Cataplexy Examples
Table Major Consumers in Narcolepsy Without Cataplexy
Figure Secondary Narcolepsy Examples
Table Major Consumers in Secondary Narcolepsy
Figure Market Share of Narcolepsy Therapeutics by Regions
Figure North America Narcolepsy Therapeutics Market Size (Million USD) (2012-2022)
Figure China Narcolepsy Therapeutics Market Size (Million USD) (2012-2022)
Figure Europe Narcolepsy Therapeutics Market Size (Million USD) (2012-2022)
Figure Southeast Asia Narcolepsy Therapeutics Market Size (Million USD) (2012-2022)
Figure Japan Narcolepsy Therapeutics Market Size (Million USD) (2012-2022)
Figure India Narcolepsy Therapeutics Market Size (Million USD) (2012-2022)
Table Narcolepsy Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Narcolepsy Therapeutics in 2016
Figure Manufacturing Process Analysis of Narcolepsy Therapeutics
Figure Industry Chain Structure of Narcolepsy Therapeutics
Table Capacity and Commercial Production Date of Global Narcolepsy Therapeutics Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Narcolepsy Therapeutics Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Narcolepsy Therapeutics Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Narcolepsy Therapeutics Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Narcolepsy Therapeutics 2012-2017
Figure Global 2012-2017E Narcolepsy Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Narcolepsy Therapeutics Market Size (Value) and Growth Rate
Table 2012-2017E Global Narcolepsy Therapeutics Capacity and Growth Rate
Table 2016 Global Narcolepsy Therapeutics Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate
Table 2016 Global Narcolepsy Therapeutics Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Narcolepsy Therapeutics Sales Price (USD/Pcs)
Table 2016 Global Narcolepsy Therapeutics Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Narcolepsy Therapeutics 2012-2017E
Figure North America 2012-2017E Narcolepsy Therapeutics Sales Price (USD/Pcs)
Figure North America 2016 Narcolepsy Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Narcolepsy Therapeutics 2012-2017E
Figure China 2012-2017E Narcolepsy Therapeutics Sales Price (USD/Pcs)
Figure China 2016 Narcolepsy Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Narcolepsy Therapeutics 2012-2017E
Figure Europe 2012-2017E Narcolepsy Therapeutics Sales Price (USD/Pcs)
Figure Europe 2016 Narcolepsy Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Narcolepsy Therapeutics 2012-2017E
Figure Southeast Asia 2012-2017E Narcolepsy Therapeutics Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Narcolepsy Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Narcolepsy Therapeutics 2012-2017E
Figure Japan 2012-2017E Narcolepsy Therapeutics Sales Price (USD/Pcs)
Figure Japan 2016 Narcolepsy Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Narcolepsy Therapeutics 2012-2017E
Figure India 2012-2017E Narcolepsy Therapeutics Sales Price (USD/Pcs)
Figure India 2016 Narcolepsy Therapeutics Sales Market Share
Table Global 2012-2017E Narcolepsy Therapeutics Sales (K Pcs) by Type
Table Different Types Narcolepsy Therapeutics Product Interview Price
Table Global 2012-2017E Narcolepsy Therapeutics Sales (K Pcs) by Application
Table Different Application Narcolepsy Therapeutics Product Interview Price
Table Addrenex Pharmaceuticals, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Business Region Distribution
Table Teva Pharmaceutical Industries Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Business Region Distribution
Table Jazz Pharmaceuticals PLC Information List
Table Product A Overview
Table Product B Overview
Table 2015 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Business Region Distribution
Table Graymark Healthcare, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Graymark Healthcare, Inc. Narcolepsy Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Graymark Healthcare, Inc. Narcolepsy Therapeutics Business Region Distribution
Table Arena Pharmaceuticals, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Business Region Distribution
Table BIOPROJET Information List
Table Product A Overview
Table Product B Overview
Table 2016 BIOPROJET Narcolepsy Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 BIOPROJET Narcolepsy Therapeutics Business Region Distribution
Table Shire Information List
Table Product A Overview
Table Product B Overview
Table 2016 Shire Narcolepsy Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Shire Narcolepsy Therapeutics Business Region Distribution
Table Ligand Pharmaceuticals, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Business Region Distribution
Figure Global 2017-2022 Narcolepsy Therapeutics Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Narcolepsy Therapeutics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Narcolepsy Therapeutics Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Narcolepsy Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Narcolepsy Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Narcolepsy Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Narcolepsy Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Narcolepsy Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Narcolepsy Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Narcolepsy Therapeutics by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Narcolepsy Therapeutics by Application 2017-2022
Table Traders or Distributors with Contact Information of Narcolepsy Therapeutics by Region